‘New method of cancer treatment to be available in India soon’

Hyderabad, Oct 15 (IANS) A new method for treating cancer, using light to destroy cancerous tissue and currently available in China, will be introduced soon in India, the technology developers said on Thursday.

The NextGeneration Photodynamic Therapy (PDT) is a safe and minimally invasive therapeutic modality to treat early and advanced cancer, which ensures that there is no toxicity and normal tissues are not destroyed.

According to NGPDT Global, one can be treated as an outpatient with little or no side effects and at a much lower cost compared to other existing forms of treatment.

NGPDT Global director Scott Waters told reporters that their strategic partners in India were in the process of getting regulatory approvals for the therapy, and it is likely to be made available in India in six to nine months.

Company representatives including research scientists and physicians are on a visit to India to explain the benefits of this treatment.

Waters said while PDT is not a new technology, they developed a novel and uniquely effective photosensitizer for use with their proprietary “whole body light delivery system” and “Near Infrared Lasers”.

Noting commonly-used cancer therapies, especially chemotherapy and radiotherapy are immuno-suppressive and highly toxic to the bone marrow, the developers said that their photosensitizer agent activated by full-body LED light bed and laser light systems, destroys only the cancer cells without any toxicity and also without damaging the normal tissues.

“The patients are given an oral photosensitizing agent. This agent collects selectively in cancer tissue and, when exposed to light, becomes activated, releasing a highly energized, free radical form of oxygen known as singlet oxygen. Singlet oxygen destroys cancer cells from the inside out, while leaving normal tissues largely unaffected,” an expert said.

Waters said a patient can be treated in one course spread over eight days, without needing any hospitalisation. A stage four cancer patient will require three courses with two week break between two courses. Even in such cases, the patient needs to stay in hospital for 50 minutes to two hours a day.

He said while average treatment for cancer in the US through existing therapies cost $1.5 million, the NextGeneration PDT will bring down the cost to $100,000.

NGPDT through its partners are working for introducing the new treatment method in 20 countries. Studies are being conducted in Australia, Britain and some other European countries.

It plans to set up treatment centres in countries like India, Malaysia and Australia.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here